Search Results - "Visentin, S"

Megalencephalic leukoencephalopathy with subcortical cysts protein-1: A new calcium-sensitive protein functionally activated by endoplasmic reticulum calcium release and calmodulin binding in astrocytes by Brignone, M S, Lanciotti, A, Molinari, P, Mallozzi, C, De Nuccio, C, Caprini, E S, Petrucci, T C, Visentin, S, Ambrosini, E

“…MLC1 is a membrane protein highly expressed in brain perivascular astrocytes and whose mutations account for the rare leukodystrophy (LD) megalencephalic…”
Get full text

3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors by Giordano, S., Morosi, L., Veglianese, P., Licandro, S. A., Frapolli, R., Zucchetti, M., Cappelletti, G., Falciola, L., Pifferi, V., Visentin, S., D’Incalci, M., Davoli, E.

“…Mass Spectrometry Imaging (MSI) is a widespread technique used to qualitatively describe in two dimensions the distribution of endogenous or exogenous…”
Get full text

OP19.05: Echocardiographic differences between late SGA and AGA fetuses by Cosmi, E., Visentin, S.

Get full text

OP19.06: Which Doppler parameter during the second trimester ultrasound should be assessed as predictor for late small‐for‐gestational‐age fetus? by Cosmi, E., Visentin, S.

Get full text

OP06.07: Middle cerebral artery pulsatility index may predict fetal cerebral injury in pregnancy complicated by cytomegalovirus infection by Cosmi, E., Visentin, S.

Get full text

EP09.22: Lipidomics in the prediction of CMV disease in fetuses with CMV infection by Cosmi, E., Visentin, S.

Get full text

Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation by De Nuccio, C., Bernardo, A., Cruciani, C., De Simone, R., Visentin, S., Minghetti, L.

“…The activation of the nuclear receptor peroxisome proliferator-activated receptor-γ (PPAR-γ) is known to exert anti-inflammatory and neuroprotective effects…”
Get full text

OP17.10: Possible new approach in the prediction of late gestational hypertension: the role of the fetal aortic intima‐media thickness by Cosmi, E., Visentin, S.

Get full text

EP17.14: Fetal endothelial remodelling in late‐onset gestational hypertension by Cosmi, E., Visentin, S.

Get full text

EP17.08: Maternal characteristics and ultrasonographic markers in third trimester might predict late gestational hypertension by Cosmi, E., Visentin, S.

Get full text

OP13.09: Associations of serum cytokines levels with fetal aortic intima‐media thickness in twin pregnancies complicated by intrauterine growth restriction by Cosmi, E., Visentin, S.

Get full text

P08.06: Normal and abnormal ductus venosus in expectant management of early IUGR fetuses and risk of adverse neonatal outcome by Cosmi, E., Visentin, S., Mari, G.

Get full text

OC14.03: Single scan screening versus longitudinal scan screening of fetal growth restriction in the third trimester: multicentre randomised protocol (RELAIS) by Familiari, A., Prefumo, F., Marco, G., Zamagni, G., Bevilacqua, E., Morlando, M., Sarno, L., Di Mascio, D., Mappa, I., Rizzo, G., Tiralongo, G., Valensise, H., Visentin, S., Fichera, A., Scambia, G., Ferrazzi, E., Stampalija, T.

Get full text

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study by RUFFATTI, Amelia, TONELLO, Marta, CANTI, Valentina, MOSCA, Marta, MITIC, Gorana, BERTERO, Maria T, PENGO, Vittorio, BOFFA, Marie C, TINCANI, Angela, VISENTIN, Maria S, BONTADI, Agnese, HOXHA, Ariela, DE CAROLIS, Sara, BOTTA, Angela, SALVI, Silvia, NUZZO, Monica, ROVERE-QUERINI, Patrizia

“…To identify the risk factors associated with pregnancy failure in patients with APS treated with conventional therapy. A multicentre, case-control study was…”
Get full text

Docosahexaenoic acid promotes oligodendrocyte differentiation via PPAR-γ signalling and prevents tumor necrosis factor-α-dependent maturational arrest by Bernardo, A., Giammarco, M.L., De Nuccio, C., Ajmone-Cat, M.A., Visentin, S., De Simone, R., Minghetti, L.

“…Docosahexaenoic acid (DHA) is an essential omega-3 fatty acid known to be neuroprotective in several models of human diseases, including multiple sclerosis…”
Get full text

OP20.10: Albuminuria and sodiuria in IUGR children by Cosmi, E., Visentin, S.

Get full text

OC09.04: Ductus venosus waveforms in expectant management of early IUGR fetuses and risk of adverse neonatal outcome: a survival analysis by Cosmi, E., Visentin, S., Londero, A., Mari, G.

Get full text

EP04.06: Contingent screening of the first trimester versus non‐invasive prenatal test: which strategy? by Cosmi, E., Duro, E., Bongiorno, M., Pinto, F., Londero, A., Visentin, S.

Get full text

EP09.16: Ecocardiographical evaluation of maternal cardiovascular function in intrauterine growth restricted fetuses by Visentin, S., Palermo, C., Muraru, D., Pinto, F., Carli, S., Badano, L., Cosmi, E.

Get full text

EP20.24: Influence of different cerebroplacental ratio charts in the predictability of late intrauterine growth restriction by Cosmi, E., Londero, A., De Virgilio, A., Giacomini, G., Pinto, F., Visentin, S.

Get full text